{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:45:13Z","timestamp":1790876713414,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00849-8","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T12:58:45Z","timestamp":1737550725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Investigation of the protective effects of dichloroacetic acid in a rat model of diabetic neuropathy"],"prefix":"10.1186","volume":"26","author":[{"given":"Murat","family":"Ar\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mumin Alper","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oytun","family":"Erba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"849_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H. Global prevalance of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047\u201353.","journal-title":"Diabetes Care"},{"key":"849_CR2","doi-asserted-by":"crossref","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Result from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019:157.","DOI":"10.1016\/j.diabres.2019.107843"},{"key":"849_CR3","doi-asserted-by":"crossref","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; Vol. 183.","DOI":"10.1016\/j.diabres.2021.109119"},{"issue":"11","key":"849_CR4","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3390\/ph16111586","volume":"16","author":"S Bana","year":"2023","unstructured":"Bana S, Kumar N, Sartaj A, et al. Rubia cordifolia L. Attenuates Diabetic Neuropathy by Inhibiting Apoptosis and Oxidative Stress in Rats. Pharmaceuticals (Basel). 2023;16(11):1586. Published 2023 Nov 9. https:\/\/doi.org\/10.3390\/ph16111586.","journal-title":"Pharmaceuticals (Basel)"},{"key":"849_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2013.12.005","volume":"80","author":"R Sing","year":"2014","unstructured":"Sing R, Kishore l, Kaur N. Diabetic Peripheral Neuropathy: current perspective and future directions. Pharmacolog Res. 2014;80:21\u201335.","journal-title":"Pharmacolog Res"},{"issue":"1","key":"849_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):42.","journal-title":"Nat Rev Dis Primers"},{"key":"849_CR7","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/jamaneurol.2014.1279","volume":"71","author":"BC Callaghan","year":"2014","unstructured":"Callaghan BC, Kerber KA, Lisabeth LL, Morgenstern LB, Longoria R, Rodgers A, et al. Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy. JAMA Neurol. 2014;71:1143\u20139.","journal-title":"JAMA Neurol"},{"key":"849_CR8","doi-asserted-by":"crossref","unstructured":"Pfannkuche A, Alhajjar A, Ming A, Walter I, Piehler C, Mertens PR. Prevalence and risk factors of diabetic peripheral neuropathy in a diabetics cohort: Register initiative diabetes and nerves. Endocr Metab Sci 2020;1.","DOI":"10.1016\/j.endmts.2020.100053"},{"key":"849_CR9","doi-asserted-by":"crossref","unstructured":"Weng YC, Tsai SS, Lyu RK, Chu CC, Ro LS, Liao MF, et al. Diabetic distal symmetrical polyneuropathy: Correlation of clinical, laboratory, and electrophysiologic studies in patients with type 2 diabetes mellitus. J Diabetes Res 2020:2020.","DOI":"10.1155\/2020\/6356459"},{"key":"849_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3923\/ijp.2023.862.871","volume":"19","author":"E Gonullu","year":"2023","unstructured":"Gonullu E, Dagistan G, \u00d6zsezer Y, Erdogan MA, Erbas O. Aesculus hippocastanum alleviates diabetic neuropathy by reducing MMP-9 and MMP-10 levels. Int J Pharmacol. 2023;19:862\u201371.","journal-title":"Int J Pharmacol"},{"issue":"7","key":"849_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jcjd.2019.11.005","volume":"44","author":"L Huang","year":"2020","unstructured":"Huang L, Zhang Y, Wang Y, Shen X, Yan S. Diabetic Peripheral Neuropathy is Associated with higher systolic blood pressure in adults with type 2 diabetes with and without hypertension in the Chinese Han Population. Can J Diabetes. 2020;44(7):615\u201323. https:\/\/doi.org\/10.1016\/j.jcjd.2019.11.005.","journal-title":"Can J Diabetes"},{"key":"849_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2019.12.003","volume":"470","author":"C Schoonjans","year":"2020","unstructured":"Schoonjans C, Joudiou N, Brusa D, Corbet C, Feron O, Gallez B. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate. Cancer Lett. 2020;470:18\u201328.","journal-title":"Cancer Lett"},{"key":"849_CR13","doi-asserted-by":"crossref","unstructured":"Gang BP, Rooke M, Sun RC, Banskota S, Mishra S, Dahlstrom JE, Blackburn AC. Pyruvate dehydrogenase kinase expression profile is a biomarker for cancer sensitivity to dichloroacetate-mediated growth inhibition. bioRxiv 2023;12.","DOI":"10.1101\/2023.09.18.557101"},{"issue":"4","key":"849_CR14","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.kint.2016.10.011","volume":"91","author":"CJ Oh","year":"2017","unstructured":"Oh CJ, Ha CM, Choi YK, et al. Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury. Kidney Int. 2017;91(4):880\u201395. https:\/\/doi.org\/10.1016\/j.kint.2016.10.011.","journal-title":"Kidney Int"},{"issue":"6","key":"849_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3390\/ph17060744","volume":"17","author":"T Koltai","year":"2024","unstructured":"Koltai T, Fliegel L. Dichloroacetate for Cancer Treatment: some facts and many doubts. Pharmaceuticals (Basel). 2024;17(6):744. https:\/\/doi.org\/10.3390\/ph17060744. Published 2024 Jun 6.","journal-title":"Pharmaceuticals (Basel)"},{"key":"849_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.etap.2017.08.037","volume":"56","author":"F Li","year":"2017","unstructured":"Li F, Dong Y, Shen H, et al. Tolerance to dichloroacetonitrile-induced neurotoxicity in streptozotocin-induced diabetic rats. Environ Toxicol Pharmacol. 2017;56:61\u20137. https:\/\/doi.org\/10.1016\/j.etap.2017.08.037.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"4","key":"849_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3171\/jns.1977.47.4.0577","volume":"47","author":"AS Rivlin","year":"1977","unstructured":"Rivlin AS, Tator CH. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg. 1977;47(4):577\u201381.","journal-title":"J Neurosurg"},{"key":"849_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by Thiobarbituric Acid reaction. Anal Biochem. 1979;95:351\u20138.","journal-title":"Anal Biochem"},{"issue":"1","key":"849_CR19","doi-asserted-by":"publisher","first-page":"853","DOI":"10.33263\/LIANBS91.853860","volume":"9","author":"S Bana","year":"2020","unstructured":"Bana S, Gaur P, Kumar N, Goel R. Lett Appl Nanobiosci. 2020;9(1):853\u201360.","journal-title":"Lett Appl Nanobiosci"},{"key":"849_CR20","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s12013-014-0365-y","volume":"71","author":"MA Babizhayev","year":"2015","unstructured":"Babizhayev MA, Strokov IA, Nosikov VV, Savel\u2019yeva EL, Sitnikov VF, Yegorov YE, et al. The role of oxidative stress in diabetic neuropathy: generation of free radical species in the glycation reaction and gene polymorphisms encoding antioxidant enzymes to genetic susceptibility to diabetic neuropathy in population of type I diabetic patients. Cell Biochem Biophys. 2015;71:1425\u201343.","journal-title":"Cell Biochem Biophys"},{"key":"849_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s004010050592","volume":"93","author":"H Sasaki","year":"2002","unstructured":"Sasaki H, Schmelzer JD, Zollman PJ, Low PA. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats. Acta Neuropathol. 2002;93:118\u201328.","journal-title":"Acta Neuropathol"},{"key":"849_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4274\/tjcd.16442","volume":"28","author":"F Ezberci","year":"2018","unstructured":"Ezberci F, \u00dcnal E. Aesculus hippocastanum (aescin, horse chestnut) in the management of hemorrhoidal disease: review. Turk J Colorectal Dis. 2018;28:54\u20137.","journal-title":"Turk J Colorectal Dis"},{"key":"849_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3923\/ijp.2023.862.871","volume":"19","author":"E Gonullu","year":"2023","unstructured":"Gonullu E, Dagistan G, Ozsezer G, Erdogan Y, Erbas MA. Aesculus hippocastanum alleviates diabetic neuropathy by reducing MMP-9 and MMP-10 levels. Int J Pharmacol. 2023;19:862\u201371.","journal-title":"Int J Pharmacol"},{"key":"849_CR24","doi-asserted-by":"crossref","unstructured":"Valauri-Orton A, Bschorer F, Bernd KK. Dichloroacetate Decreases Cell Health and Activates Oxidative Stress Defense Pathways in Rat Alveolar Type II Pneumocytes. Biomed Res Int. 2015;2015:129031.","DOI":"10.1155\/2015\/129031"},{"issue":"3","key":"849_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ygyno.2008.01.038","volume":"109","author":"JY Wong","year":"2008","unstructured":"Wong JY, Huggins GS, Debidda M, Munshi NC, De Vivo I. Dichloroacetate induces apoptosis in endometrial cancer cells. Gynecol Oncol. 2008;109(3):394\u2013402.","journal-title":"Gynecol Oncol"},{"key":"849_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2337\/diab.32.10.938","volume":"32","author":"RJ Young","year":"1983","unstructured":"Young RJ, Ewing DJ, Clarke BF. A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes. 1983;32:938\u201342.","journal-title":"Diabetes"},{"key":"849_CR27","first-page":"433","volume":"21","author":"DH Akbar","year":"2000","unstructured":"Akbar DH, Mira SA, Zawawi TH. Subclinical diabetic neuropathy. A common complication in Saudi diabetics. Saudi Med J. 2000;21:433\u20137.","journal-title":"Saudi Med J"},{"key":"849_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJM199507133330203","volume":"333","author":"J Partanen","year":"1995","unstructured":"Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. New Engl J Med. 1995;333:89\u201394.","journal-title":"New Engl J Med"},{"key":"849_CR29","doi-asserted-by":"publisher","unstructured":"Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the rochester diabetic neuropathy study. Neurology. 1993;43. https:\/\/doi.org\/10.1212\/WNL.43.4.817.","DOI":"10.1212\/WNL.43.4.817"},{"issue":"6","key":"849_CR30","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1185\/030079907X188215","volume":"23","author":"M Happich","year":"2007","unstructured":"Happich M, Breitscheidel L, Meisinger C, Ulbig M, Falkenstein P, Benter U, et al. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study. Curr Med Res Opin. 2007;23(6):1367\u201374.","journal-title":"Curr Med Res Opin"},{"key":"849_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/dmrr.2257","volume":"28","author":"H Andersen","year":"2012","unstructured":"Andersen H. Motor dysfunction in diabetes. Diabetes Metab Res Rev. 2012;28:89\u201392.","journal-title":"Diabetes Metab Res Rev"},{"key":"849_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/mus.20785","volume":"36","author":"DW Zochodne","year":"2007","unstructured":"Zochodne DW. Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms. Muscle Nerve. 2007;36:144\u201366.","journal-title":"Muscle Nerve"},{"key":"849_CR33","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115:1627\u201335.","journal-title":"J Clin Invest"},{"key":"849_CR34","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/en.2006-1168","volume":"148","author":"A Kharitonenkov","year":"2007","unstructured":"Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology. 2007;148:774\u201381.","journal-title":"Endocrinology"},{"key":"849_CR35","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.2337\/db05-1435","volume":"55","author":"W Wente","year":"2006","unstructured":"Wente W, Efanov AM, Brenner M, Kharitonenkov A, K\u00f6ster A, Sandusky GE, et al. Fibroblast growth factor-21 improves pancreatic \u03b2-cellfunction and survival by activation of extracellular signal\u2013regulated kinase 1\/2 and akt signalingp athways. Diabetes. 2006;55:2470\u20138.","journal-title":"Diabetes"},{"issue":"10","key":"849_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0315-2","volume":"30","author":"BK Min","year":"2019","unstructured":"Min BK, Oh CJ, Park S, Lee JM, Go Y, Park BY, et al. Therapeutic effect of dichloroacetate against atherosclerosis via hepatic FGF21 induction mediated by acute AMPK activation. Exp Mol Med. 2019;30(10):1\u201312.","journal-title":"Exp Mol Med"},{"issue":"1","key":"849_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1758-5996-5-48","volume":"31","author":"S Pscherer","year":"2013","unstructured":"Pscherer S, Freude T, Forst T, Nussler AK, Braun KF, Ehnert S. Anti-diabetic treatment regulates pro-fibrotic TGF-\u03b2 serum levels in type 2 diabetics. Diabetol Metab Syndr. 2013;31(1):48.","journal-title":"Diabetol Metab Syndr"},{"key":"849_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/archotol.1996.01890140057011","volume":"122","author":"AV Nall","year":"1996","unstructured":"Nall AV, Brownlee RE, Colvin CP, Schultz G, Fein D, Cassisi NJ, et al. Transforming growth factor beta 1 improves wound healing and random flap survival in normal and irradiated rats. Arch Otolaryngol Head Neck Surg. 1996;122:171\u20137.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"849_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/13880200903085466","volume":"48","author":"G Avci","year":"2010","unstructured":"Avci G, K\u00fc\u00e7\u00fckkurt I, Akkol EK, Ye\u015filada E. Effects of escin mixture from the seeds of Aesculus hippocastanum on obesity in mice fed a high fat diet. Pharm Biol. 2010;48:247\u201352.","journal-title":"Pharm Biol"},{"key":"849_CR40","first-page":"107","volume":"17","author":"N Choudhary","year":"2021","unstructured":"Choudhary N, Khatik GL, Suttee A. The possible role of saponin in type-II diabetes-A review. Curr Diabetes Rev. 2021;17:107\u201321.","journal-title":"Curr Diabetes Rev"},{"key":"849_CR41","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1055\/s-0035-1550019","volume":"123","author":"T Cavusoglu","year":"2015","unstructured":"Cavusoglu T, Karadeniz T, Cagiltay E, Karadeniz M, Yigitturk G, Acikgoz E, et al. The protective effect of losartan on diabetic neuropathy in a diabetic rat model. Exp Clin Endocrinol Diabetes. 2015;123:479\u201384.","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00849-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00849-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00849-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T12:58:50Z","timestamp":1737550730000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00849-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["849"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00849-8","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"17 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures adhered to the ethical guidelines approved by the Institutional Animal Care and Ethical Committee of the University of Science (Ethical Approval Number: 28210104, Date:13.02.2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}